CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Related Content
A Mental Health Bill Everyone Can Agree On
Bipartisan legislation would help kids get mental health care earlier.
CHA Statement on Budget Reconciliation Bill
The budget includes significant cuts to Medicaid and will detrimentally impact children across the nation.
CHA Opposes Proposed Cuts to Medicaid Program
If enacted, these cuts would threaten health care access for millions of children.